Intervention

SSRI

ClinicalTrials.gov intervention label

Clinical trials16

Recruiting1

Common conditions11

Lead sponsors shown10

Clinical trials

16 shown

Non-invasive BCI and Application Verification for Depressed PeopleNCT06417437 · 2023-07-01

MAGNESIUM & SSRI VS SSRI ALONE AMONG PATIENTS OF MAJOR DEPRESSIVE DISORDERNCT07458022 · 2025-12-01

ACTIVE_NOT_RECRUITING

A Database Survey of Comparison The Risk of Haemorrhage Between Vortioxetine Tablet Treatment and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment in Participants With DepressionNCT05932407 · 2024-06-01

The Efficacy and Cerebral Mechanism of Intradermal Acupuncture for Major Depressive DisorderNCT05720637 · 2022-11-01

Intradermal Acupuncture Versus Sham Acupuncture and SSRI for Treating Adolescents With Major Depressive DisorderNCT05832619 · 2022-11-01

SSRI's and the Rate of Progression From MCI to DementiaNCT04901494 · 2021-09-01

Stepped Care AiTBS 2 Depression Study (Ghent)NCT03288675 · 2017-10-05

Efficacy of Vortioxetine on Cognitive Dysfunction in Patients With Partial or Full Remission of Major Depressive DisorderNCT02279953 · 2014-10-01

A Study of LY2216684 in Participants With Major Depression DisorderNCT01370499 · 2011-08-01

A Study in Prevention of Re-emergence of Depression SymptomsNCT01299272 · 2011-05-01

A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake InhibitorNCT01185340 · 2011-03-01

A Study of Flexible or Fixed Dose LY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) TreatmentNCT01187407 · 2011-03-01

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive DisorderNCT01173601 · 2010-11-01

A Safety Study in Participants With Major Depressive DisorderNCT01155661 · 2010-10-01

Imaging Antidepressant vs. Cognitive Behavior Therapy Effects on Unipolar DepressionNCT00787501 · 2008-06-01

Study Comparing the Efficacy of Venlafaxine XR Vs. SSRIs and Conventional Antidepressants in Depressed PatientsNCT00474708 · 2007-04-01

Common conditions

Major Depressive Disorder11 Depressive Disorder, Major2 Alzheimer Disease1 Bipolar Depression1 Dementia1 Depression1 Major Depressive Diorder1 Major Depressive Disorder (MDD)1 Melancholia1 Mild Cognitive Impairment1 Treatment Resistant Depression1

Leading sponsors

Eli Lilly and Company6 Xiaomei Shao2 H. Lundbeck A/S1 Ohio State University1 Shanghai Mental Health Center1 Takeda1 University Hospital, Ghent1 University of Child Health Sciences and Children's Hospital, Lahore1 University of Pittsburgh1 Wyeth is now a wholly owned subsidiary of Pfizer1

Trial status mix

COMPLETED12

ACTIVE_NOT_RECRUITING1

RECRUITING1

UNKNOWN1

WITHDRAWN1

Phase mix

PHASE37

NA3

PHASE42

PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.